 |
We are currently doing a project with the aim to analyse new companies which are developing disease management tools (DMT) of Alzheimer and Dementia.
We are currently doing an exploratory internal project together with a pharma company to evaluate innovative disease management tools within Alzheimer / Dementia.
Decision makers are generally used to evaluating data according to its internal validity, as has been the case for RCTs, however by doing this, understanding for the specifics for a disease or inte
This is a summary of the pilot study regarding the development of a value-based monitoring platform for bariatric surgery in Sweden.